Centessa Pharmaceuticals to Present at Upcoming Conferences in 2021

BOSTON and LONDON, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc ("Company") CNTA today announced that Saurabh Saha, MD, PhD, Chief Executive Officer, will present at the following investor conferences:

Event: Jefferies London Healthcare Conference

Date: Thursday, November 18, 2021

Presentation Details: Recording available on-demand on Thursday, November 18, 2021, starting at 3:00 AM ET (8:00 GMT)

Event: Evercore ISI HealthCONx Conference

Date: Thursday, December 2, 2021

Fireside Chat Details: 4:20 PM ET (21:20 GMT)

Access to the live webcasts of these events, as well as archived recordings, will be available under the "Events" tab on the investor relations section of the Centessa Pharmaceuticals website at https://investors.centessa.com/events-presentations.

About Centessa Pharmaceuticals

Centessa Pharmaceuticals plc aims to bring impactful new medicines to patients by combining the strengths of an asset-centric model with the benefits of scale and diversification typical of larger R&D organizations. The asset-centric model refers to a highly specialized, singular-focused company that is led by a team of well-recognized subject matter experts. Centessa's asset-centric companies' programs range from discovery-stage to late-stage development and include diverse therapeutic areas such as oncology, hematology, immunology/inflammation, neuroscience, hepatology, pulmonology and nephrology. For more information, visit www.centessa.com.

Contacts:

Investors:

Jennifer Porcelli, Head of Investor Relations

Centessa Pharmaceuticals

jennifer.porcelli@centessa.com

Media:

1AB

Dan Budwick

dan@1abmedia.com 



Primary Logo

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!